Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT04451369

Connected Prehabilitation Program During Neo Adjuvant Chemotherapy

NACT is a heavy oncologic treatment, which can impair functional capacity, nutritional and emotional status. These three impairments are often ignored and not taken into account in the pre-therapeutic evaluations but are correlated with postoperative morbidity and mortality after major surgery.

Recently, a prehabilitation before surgery, including physical, nutritional and psycho-social support, has been defined. From a literature review, the maximum oxygen uptake (VO2 max) seems to constitute a strong evaluation factor reflecting physical fitness, easily measured with a cardiopulmonary exercise test (CPET) at maximal effort.

Several studies have shown beneficial effects of trimodal prehabilitation programs on postoperative functional capacity, return to daily activities and pain relief.

Home-based program and connected devices may improve the feasibility and the compliance to this program.

The hypothesis of this study is that performing a connected supervised home-based and patient-tailored multimodal prehabilitation program from diagnosis to surgery (with or without ERAS program) during NACRT, for patients managed for ovarian cancer, will limit physical fitness alteration and will positively affect postoperative outcomes.

Our study consists in an early and multidimensional (combining nutritional, physical, emotional and medical support) prehabilitation program during NACT for patients with ovarian cancer, in order to limit physical alteration before surgical treatment, and therefore improve postoperative outcomes. It will include a home-based prehabilitation program, in order to allow care access to all eligible patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

The main objective will be to determine if a prehabilitation program during NACT, for patients treated for an advanced ovarian cancer will limit physical alteration before major abdomino-pelvic surgery, compared to a control group without prehabilitation program. The primary endpoint will be the comparison of the variation of VO2 max, between baseline and surgery, in the prehabilitation group vs control group: VO2 max will be measured with a cardiopulmonary exercise test (CPET) at maximal effort.

This prospective, multicentric randomized control trial will be conducted in 7 French comprehensive cancer Centers or University Hospital, in compliance with inclusion criteria. After an initial evaluation, patients will be randomized in two groups: Prehabilitation group (P group) and a Control group (C group).

For the P group, after baseline evaluation, we will be offering from diagnosis to surgery, during the NACT:

  • A standardized, patient-tailored preoperative physical activity training program will be performed at home, from diagnosis to surgery. Supervision will be done with connected device (connected watches) and activity will be adapted,
  • A nutritional care established in respect of the SFNEP-SFNCM guidelines. Nutritional support will be adapted by a dietician according to information transmitted daily (connected body fat weight scale),
  • A psychological support with coping strategies.

For the C group: Patients with ovarian cancer will undergo NACT after baseline evaluation without prehabilitation program.

After NACT, for both groups, major abdomino-pelvic surgery will be done with or without ERAS pathway, according to the practice in each center.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient must have signed the written consent,
  • Age ≥ 18 years,
  • Patient with advanced ovarian cancer (AOC), FIGO Stage III - IV, undergoing surgery,
  • Patient with neo adjuvant chemotherapy (min 3 cycles, max 6 cycles),
  • Capability to perform a cardiopulmonary exercise test (CPET)
  • Patient affiliated to the national "Social Security" regimen or beneficiary of this regimen.

Exclusion criteria

  • Patient with cognitive impairment,
  • Pregnancy,
  • Neoadjuvant treatment contraindications,
  • Physical adapted activity program contraindication,
  • No possibility to have access to connected devices or do not have a smartphone or a computer
  • Patient deprived of liberty or placed under the authority of a tutor,
  • Patient considered socially or psychologically unable to comply with the procedure and the required medical follow-up.

Treatment and study plan

Prehabilitation program

Other

physical, nutritional and psycho-social supports before surgery

Primary outcomes

  1. To determine if a prehabilitation program during NACT, for patient managed with advanced ovarian cancer (AOC) will limit physical alteration before surgery, compared to a control group without prehabilitation program (change between 3 timepoints).

    Time frame: baseline, 15 days before surgery and 3 moths before surgery

    CHANGE of VO2 max between baseline (inclusion) and surgery (preoperative), in the prehabilitation group vs control group. VO2 max will be measured during a cardiopulmonary exercise test (CPET).

Secondary outcomes

  1. to compare physical outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    o International Physical Activity Questionnaire (IPAQ) , administered at inclusion and at the time of surgery and after surgery

  2. to compare physical outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    Muscular strength evaluated with dynamometer (brachial biceps)

  3. to compare Quality of Life, emotional outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    Psychological status evaluated by the Hospital Anxiety and Depression Scale (HADS) (Annex 2)

  4. to compare Quality of Life, emotional outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    Cancer related quality of life (QoL) evaluated by using the self-reported European Organization for Research and Treatment of Cancer (EORTC) core questionnaire (QLQ-C30) (Annex 3)

  5. to compare Quality of Life, emotional outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    Motivation evaluated by a free interview and a coping strategy.

  6. to compare nutritional outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    Change Body Mass Index (BMI)

  7. to compare nutritional outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    Muscle mass evaluated with the Computed tomography-derived

  8. to compare nutritional outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    skeletal muscle index measured by skeletal muscle mass cross-sectional area at L3/height2

  9. to compare nutritional outcomes between both groups

    Time frame: baseline, before surgery, and 3 months after surgery

    Weight in kg

  10. to compare Surgical Morbidity rate between both groups

    Time frame: at day 30 and day 90 (3 months) after surgery

    Clavien-Dindo classification

  11. to compare Surgical Morbidity rate between both groups

    Time frame: at day 30 and day 90 (3 months) after surgery

    NCI-CTCAE v 5.0 classification

Study contacts

Contact information is provided by the study sponsor or research team.

Dominique GENRE, Dr

CONTACT

[email protected]

+33 4 91 22 37 78

Sponsors and collaborators

Lead sponsor

Institut Paoli-Calmettes

Other

Registry information

Official study title

Multicenter Randomized Study Comparing Neo Adjuvant Chemotherapy for Patients Managed for Ovarian Cancer With or Without a Connected Prehabilitation Program

Acronym: TRAINING

Important dates

Study start
2021
Primary completion
2022
Study completion
2027
First posted
Jun 30, 2020
Registry last updated
Feb 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.